Front Row Advisors LLC Eli Lilly & CO Transaction History

Front Row Advisors LLC

$271 Million
Q3 2024

A detailed history of Front Row Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Front Row Advisors LLC holds 303 shares of LLY stock, worth $220,341. This represents 0.1% of its overall portfolio holdings.

Number of Shares

303

Previous 1,266 76.07%

Holding current value

$220,341

Previous $1.15 Million 76.61%

% of portfolio

0.1%

Previous 0.41%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $743,570 - $924,499	-963 Reduced 76.07%	303 $268,000
Q2 2024 Aug 15, 2024	SELL	$724.87 - $909.04 $181,217 - $227,260	-250 Reduced 16.49%	1,266 $1.15 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $570,288 - $762,965	963 Added 174.14%	1,516 $1.18 Million
Q4 2023 Feb 15, 2024	SELL	$525.19 - $619.13 $505,232 - $595,603	-962 Reduced 63.5%	553 $322,000
Q3 2023 Nov 15, 2023	BUY	$434.7 - $599.3 $46,512 - $64,125	107 Added 7.6%	1,515 $813,000
Q1 2023 May 22, 2023	BUY	$310.63 - $364.82 $287,022 - $337,093	924 Added 190.91%	1,408 $484,000
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $270,558 - $317,758	-871 Reduced 64.28%	484 $141,000
Q4 2022 Feb 15, 2023	SELL	$321.55 - $374.67 $11,254 - $13,113	-35 Reduced 2.52%	1,355 $496,000
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $1,185 - $1,351	-4 Reduced 0.29%	1,390 $450,000
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $1,173 - $1,458	-5 Reduced 0.36%	1,394 $399,000
Q1 2021 Apr 28, 2021	SELL	$164.32 - $212.72 $328 - $425	-2 Reduced 0.14%	1,399 $261,000
Q3 2020 Nov 30, 2020	SELL	$146.22 - $169.13 $46,936 - $54,290	-321 Reduced 18.64%	1,401 $207,000
Q1 2020 May 08, 2020	BUY	$119.05 - $147.35 $6,190 - $7,662	52 Added 3.11%	1,722 $266,000
Q4 2019 Feb 14, 2020	SELL	$106.92 - $132.43 $534 - $662	-5 Reduced 0.3%	1,670 $219,000
Q3 2019 Nov 08, 2019	BUY	$106.79 - $116.16 $106 - $116	1 Added 0.06%	1,675 $187,000
Q1 2019 May 17, 2019	BUY	$111.31 - $131.02 $3,673 - $4,323	33 Added 2.01%	1,674 $217,000
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $1,717 - $2,146	20 Added 1.23%	1,641 $174,000
Q4 2017 Feb 01, 2018	BUY	$81.94 - $87.89 $132,824 - $142,469	1,621	1,621 $137,000

Others Institutions Holding LLY

# of Institutions

4,002

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $691B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Account

Front Row Advisors LLC Eli Lilly & CO Transaction History